Alto Ingredients vs Ingevity
Ingevity reported revenue of $1.2 billion in fiscal 2025, 1.3 times Alto Ingredients' $918 million in fiscal 2025. Alto Ingredients' revenue fell 4.9% in its latest year, and Ingevity's fell 2.7%. Alto Ingredients had an operating margin of 0.8%, against 35.9% at Ingevity. Free cash flow was $9 million at Alto Ingredients and $274 million at Ingevity.
Side by side
| Alto Ingredients | Ingevity | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $918M | $1.2B |
| Revenue growth | −4.9% | −2.7% |
| Revenue growth a year, last 5 years | 0.5% | −0.8% |
| Gross margin | 3.8% | 39.5% |
| Operating margin | 0.8% | 35.9% |
| Net margin | 1.4% | −14.3% |
| Free cash flow | $9M | $274M |
| Free cash flow margin | 0.9% | 23.4% |
| Return on capital | 2.5% | 24.6% |
| Net debt to EBITDA | 1.9x | 2.1x |
| Dividends and buybacks | $0M | $56M |
| Change in diluted share count | 3.0% | −0.3% |
| Last close | $3.66 | $61.72 |
| P/E at the last close | 5.6× | 35.7× |
| Insider trades, last 12 months | bought $361,250, sold $0 | sold $1.8 million |
| Piotroski F-score | 6 of 9 | 6 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Alto IngredientsIngevity
Operating margin
Percent of revenue
Alto IngredientsIngevity
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Alto IngredientsIngevity
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Alto Ingredients and Ingevity pages.